|
ZNF570 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.94950000037753E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.44910000002374E-06 |
| Normal-vs-Stage2 |
8.27860000000014E-05 |
| Normal-vs-Stage3 |
2.661100E-03 |
| Normal-vs-Stage4 |
2.218200E-02 |
| Stage1-vs-Stage2 |
5.583200E-01 |
| Stage1-vs-Stage3 |
8.765400E-01 |
| Stage1-vs-Stage4 |
5.488200E-01 |
| Stage2-vs-Stage3 |
7.011400E-01 |
| Stage2-vs-Stage4 |
8.636400E-01 |
| Stage3-vs-Stage4 |
6.664200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.86250000042432E-07 |
| Normal-vs-AfricanAmerican |
1.186870E-04 |
| Normal-vs-Asian |
5.00319999874321E-08 |
| Caucasian-vs-AfricanAmerican |
7.005400E-01 |
| Caucasian-vs-Asian |
3.937600E-03 |
| AfricanAmerican-vs-Asian |
4.001900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.27510000336173E-08 |
| Normal-vs-Female |
4.728100E-02 |
| Male-vs-Female |
2.924400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.037200E-04 |
| Normal-vs-Extreme_Weight |
2.7949999981125E-08 |
| Normal-vs-Obese |
2.704600E-03 |
| Normal-vs-Extreme_Obese |
1.400700E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.432400E-01 |
| Normal_Weight-vs-Obese |
2.809800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.810000E-01 |
| Extreme_Weight-vs-Obese |
1.910230E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.805800E-01 |
| Obese-vs-Extreme_Obese |
1.224810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.538470E-03 |
| Normal-vs-Age(41-60Yrs) |
3.628000E-04 |
| Normal-vs-Age(61-80Yrs) |
4.59390000484561E-08 |
| Normal-vs-Age(81-100Yrs) |
2.35090000000326E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.808000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.891800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.225400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.470100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.914360E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.645000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.23659999970738E-07 |
| Normal-VS-Type2 PRCC |
1.01969999999341E-06 |
| Normal-VS-KIRP CIMP |
1.278630E-03 |
| Normal-VS-Unclassified PRCC |
7.760400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.523600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.679800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.871640E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.367200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.882100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.090200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.31779998024939E-09 |
| Normal-vs-N1 |
2.618400E-02 |
| Normal-vs-N2 |
2.34309999999072E-05 |
| N0-vs-N1 |
1.435560E-01 |
| N0-vs-N2 |
1.702430E-01 |
| N1-vs-N2 |
1.539360E-01 |
|
|
